JPS5854126B2 - Leukocyte separation material - Google Patents

Leukocyte separation material

Info

Publication number
JPS5854126B2
JPS5854126B2 JP53024455A JP2445578A JPS5854126B2 JP S5854126 B2 JPS5854126 B2 JP S5854126B2 JP 53024455 A JP53024455 A JP 53024455A JP 2445578 A JP2445578 A JP 2445578A JP S5854126 B2 JPS5854126 B2 JP S5854126B2
Authority
JP
Japan
Prior art keywords
fibers
blood cells
filter
leukocyte
microns
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP53024455A
Other languages
Japanese (ja)
Other versions
JPS54119013A (en
Inventor
良則 竹中
信明 津田
徹 黒田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Chemical Industry Co Ltd
Original Assignee
Asahi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Industry Co Ltd filed Critical Asahi Chemical Industry Co Ltd
Priority to JP53024455A priority Critical patent/JPS5854126B2/en
Priority to GB7907537A priority patent/GB2018151B/en
Priority to FR7905629A priority patent/FR2419073A1/en
Priority to DE2908722A priority patent/DE2908722C2/en
Publication of JPS54119013A publication Critical patent/JPS54119013A/en
Priority to US06/170,384 priority patent/US4330410A/en
Publication of JPS5854126B2 publication Critical patent/JPS5854126B2/en
Expired legal-status Critical Current

Links

Landscapes

  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Filtering Materials (AREA)

Description

【発明の詳細な説明】 本発明は白血球分離材に関するものである。[Detailed description of the invention] The present invention relates to a leukocyte separation material.

さらに詳しく述べると、平均直径が10ミクロン以下の
、血液を変性させない合成繊維、半合成繊維再生人造繊
維、無機繊維または天然繊維からなる白血球分離材に関
するものである。
More specifically, the present invention relates to a leukocyte separation material made of synthetic fibers, semi-synthetic fibers, regenerated artificial fibers, inorganic fibers, or natural fibers that do not denature blood and have an average diameter of 10 microns or less.

近年、血液学、免疫学の発達により、従来の全血輸血に
代わって、赤血球、白血球、白血球のなかでも顆粒球、
リンパ球などの、血液中の特定の成分のみを種々の患者
に輸血する成分輸血が行われるようになってきた。
In recent years, with the development of hematology and immunology, in place of conventional whole blood transfusion, transfusions of red blood cells, white blood cells, and granulocytes among white blood cells are being used.
Component transfusion, in which only specific components of blood, such as lymphocytes, are transfused to various patients has come to be performed.

この成分輸血は患者にとつて不必要か、または害をもつ
成分を除き、必要な成分を多量濃縮して輸血できるとい
う大きな利点をもっている。
This component transfusion has the great advantage that components unnecessary or harmful to the patient can be removed and necessary components can be concentrated and transfused in large quantities.

現在よく行われているのは、白血球数が異常に低下して
、細菌などの感染により発熱した患者に対する白血球輸
血や顆粒球輸血、種々の免疫療法のためのリンパ球輸血
、赤血球のみを必要とする患者のための赤血球輸血など
である。
Currently, the most common treatments are leukocyte transfusions and granulocyte transfusions for patients with abnormally low white blood cell counts and fever due to bacterial infection, lymphocyte transfusions for various immunotherapies, and transfusions that require only red blood cells. such as red blood cell transfusions for patients who

このような目的のために使用できる従来の白血球の分離
法としては、各種血球に作用する凝集剤を用いる方法や
、遠心分離操作、血球を粘着・付着または吸着する物質
を用いる方法などが利用されている。
Conventional leukocyte separation methods that can be used for this purpose include methods that use aggregating agents that act on various types of blood cells, centrifugation operations, and methods that use substances that stick, adhere, or adsorb blood cells. ing.

凝集剤を用いる方法としては、たとえば血液にデキスト
ランやヒドロキシエチルスターチなどの赤血球凝集剤を
加え、赤血球を沈降させ、白血球を得る方法であるが、
得られる白血球の純度が良くなく、時間もかかる。
An example of a method using an agglutinating agent is to add a red blood cell aggregating agent such as dextran or hydroxyethyl starch to blood and sediment the red blood cells to obtain white blood cells.
The purity of the white blood cells obtained is not good and it takes a long time.

遠心分離操作を用いる方法としては、たとえば密度の異
なる液を重層し、その上に血液をのせて遠心分離し、血
球の比重の違いにより分離するものなどがあるが、多量
の血液を処理するのが困難である。
Examples of methods using centrifugation include layering liquids with different densities, placing blood on top of the layers, and centrifuging the layers to separate blood cells based on the differences in specific gravity; however, it is difficult to process large amounts of blood. is difficult.

また血球を付着する性質を用いるものとしては、ナイロ
ン繊維、ポリエステル繊維、綿、シリコン処理ガラスウ
ールなどに顆粒球・単球がよく粘着する性質を利用した
ものがあるが、リンパ球は一般にこれらの物質に対する
粘着能が弱く、これらの物質のみでは白血球全体を一度
に分離することはできなかった。
In addition, there are methods that utilize the property of granulocytes and monocytes to adhere well to nylon fibers, polyester fibers, cotton, silicone-treated glass wool, etc., but lymphocytes generally do not adhere to these materials. Due to their weak adhesion to substances, it was not possible to separate all white blood cells at once using these substances alone.

そこで本発明者らは、多量の血液から簡単な操作で純度
・収率良く白血球を分離する方法について鋭意検討した
結果、顆粒球・単球のみならず、リンパ球も多量捕捉し
、赤血球などを余り捕捉しない分離材を見出し、本発明
を完成させるにいたった。
Therefore, the present inventors conducted extensive research into a method for separating white blood cells from a large amount of blood with simple operations and high yield.As a result, they were able to capture large amounts of not only granulocytes and monocytes, but also lymphocytes, and remove red blood cells. They found a separation material that does not trap much, and completed the present invention.

すなわちこの発明は、平均直径が10ミクロン以下の、
血液を変性させない合成繊維、半合成繊維、再生人造繊
維、無機繊維または天然繊維からなることを特徴とする
白血球分離材である。
In other words, the present invention provides a material having an average diameter of 10 microns or less.
This leukocyte separation material is characterized by being made of synthetic fibers, semi-synthetic fibers, regenerated artificial fibers, inorganic fibers, or natural fibers that do not denature blood.

本発明でいう血液、体液またはこれらを処理して得られ
る血球浮遊液とは、血液や体液、たとえば腹水や骨髄液
それ自身、およびこれらの液に何らかの処理、たとえば
デキストランやヒドロキシエチルスターチなどの赤血球
凝集剤のような血球凝集剤を加えて得た血球浮遊液や、
密度勾配遠心分離などのような遠心分離操作により得た
血球浮遊液、細胞電気泳動により得られた血球浮遊液な
どをいう。
In the present invention, blood, body fluids, or a blood cell suspension obtained by processing these are blood or body fluids, such as ascites or bone marrow fluid themselves, and these fluids may be treated in some way, such as by adding red blood cells such as dextran or hydroxyethyl starch. A blood cell suspension obtained by adding a hemagglutinating agent such as a coagulant,
Refers to blood cell suspensions obtained by centrifugation operations such as density gradient centrifugation, blood cell suspensions obtained by cell electrophoresis, etc.

また本発明でいう繊維とは、そのものの平均直径に比べ
て長さが非常に長いものである。
Furthermore, the term fiber as used in the present invention refers to a fiber whose length is much longer than its average diameter.

平均直径(D)とは、そのものの重さをx?、長さをy
備、密度をρt/crrtとすると、D=21””;(
m)πy で定義されるものをいう。
The average diameter (D) is the weight of the object x? , the length is y
If the density is ρt/crrt, then D=21'';(
m) πy.

本発明による平均直径が10ミクロン以下の、血液を変
性させない合成繊維、半合成繊維、再生人造繊維、無機
繊維、天然繊維などは、血液から白血球を選択的に短時
間に捕捉・分離できる。
The synthetic fibers, semi-synthetic fibers, regenerated artificial fibers, inorganic fibers, natural fibers, etc., which do not denature blood and have an average diameter of 10 microns or less according to the present invention, can selectively capture and separate leukocytes from blood in a short time.

すなわち、これらの繊維をカラムにつめたフィルターに
血液を流すと、血液中の白血球の大部分、および一部の
赤血球がフィルターに残る。
In other words, when blood is passed through a filter containing these fibers in columns, most of the white blood cells and some red blood cells remain in the filter.

つぎにフィルター内の白血球がほとんど回収されないよ
うな生理的溶液、たとえば生理的食塩水やリン酸緩衝生
理食塩水などを上記フィルターに流すと、フィルター内
に残っている赤血球の大部分がフィルターから出てくる
が、白血球はほとんど出てこない。
Next, when a physiological solution such as physiological saline or phosphate buffered saline that hardly collects the white blood cells in the filter is passed through the filter, most of the red blood cells remaining in the filter will come out of the filter. However, almost no white blood cells come out.

つぎに、捕捉された白血球を何らかの処理により回収す
ると、白血球浮遊液が得られる。
Next, the captured leukocytes are recovered by some treatment to obtain a leukocyte suspension.

この時、残っていた赤血球なども少し混じるが、最初の
赤血球数と比べると比較にならないぐらい少量である。
At this time, some remaining red blood cells are mixed in, but the amount is incomparably small compared to the initial number of red blood cells.

このように、平均直径が10ミクロン以下の繊維は白血
球をよく捕捉するが、考えられる機構としては、細い繊
維をカラムにつめると、繊維と繊維の間隔がこれまでの
太い繊維に比べ非常に小さくでき、このため顆粒球・単
球のみならず、リンパ球も繊維のすきまに捕捉されるこ
とや、繊維が細いため、繊維表面積を非常に大きくでき
ること、および、リンパ球や顆粒球・単球の大きさが8
〜15ミクロンであるので、白血球よりも直径の小さい
、径が10ミクロン以下の本願の繊維にくっつきやすい
ことなどがあげられる。
In this way, fibers with an average diameter of 10 microns or less capture white blood cells well, but one possible mechanism is that when thin fibers are packed into a column, the spacing between the fibers is much smaller than that of conventional thick fibers. For this reason, not only granulocytes and monocytes, but also lymphocytes are trapped in the gaps between the fibers, and because the fibers are thin, the fiber surface area can be made extremely large, and lymphocytes, granulocytes, and monocytes are size is 8
~15 microns, which means that they tend to stick to the fibers of the present invention, which have a diameter smaller than white blood cells and have a diameter of 10 microns or less.

本発明に用いる平均直径が10ミクロン以下の繊維は、
血液を変性させないものであればよく、ポリアミド、ポ
リエステル、ポリアクリロニトリル系、ポリテトラフル
オロエチレンなどの合成繊維、アセテートなどの半合成
繊維、銅アンモニアレーヨンなどの再生人造繊維、ガラ
ス繊維などの無機繊維、綿、絹糸、羊毛などの天然繊維
が用いられる。
The fibers used in the present invention have an average diameter of 10 microns or less,
Any material that does not denature blood may be used, such as synthetic fibers such as polyamide, polyester, polyacrylonitrile, and polytetrafluoroethylene, semi-synthetic fibers such as acetate, recycled artificial fibers such as copper ammonia rayon, inorganic fibers such as glass fiber, Natural fibers such as cotton, silk, and wool are used.

なかでも1.ポリアミド、ポリエステル、ポリアクリロ
ニトリル系などの合成繊維やアセテートなどの半合成繊
維は、10ミクロン以下の平均直径の繊維を用いると、
著しく高い白血球捕捉力を示す。
Among them, 1. Synthetic fibers such as polyamide, polyester, and polyacrylonitrile, and semi-synthetic fibers such as acetate, have an average diameter of 10 microns or less.
Shows significantly high leukocyte capture ability.

平均直径が10ミクロンより大きい繊維でも、カラムに
多量つめ込むと、かなり白血球捕捉力を示す。
Even fibers with an average diameter larger than 10 microns exhibit considerable leukocyte-capturing power when packed in large quantities into a column.

しかしながら、同一表面積の条件下、すなわち、用いた
糸の量が、平均直径10ミクロン以下の繊維よりも大き
い時でも、平均直径10ミクロンより大きい繊維のほう
が、白血球捕捉力は劣る。
However, even under conditions of the same surface area, ie, when the amount of thread used is larger than that of fibers with an average diameter of 10 microns or less, fibers with an average diameter of more than 10 microns have inferior leukocyte capture power.

このような平均直径10ミクロン以下の繊維からなる分
離材を輸血に用いる際は、繊維表面の仕上げ剤などを除
去するとともに、表面に吸着しているゴミをとり除くこ
とが望ましい。
When such a separation material made of fibers with an average diameter of 10 microns or less is used for blood transfusion, it is desirable to remove finishing agents and the like on the fiber surface as well as remove dust adsorbed to the surface.

また、フィルターとするときに、上記繊維を2次加工物
の形とした分離材を使用してもよい。
Further, when making a filter, a separation material in which the above-mentioned fibers are made into a secondary product may be used.

種々の繊維の白血球捕捉力を第1図に示した。Figure 1 shows the leukocyte-capturing power of various fibers.

第1図は、種々の繊維を直径1cIfLのカラムに、密
度0.085S’/−となるようにつめたフィルターに
、まずヘハリン加した血液を20一流し、つぎに生理食
塩水を50m1流して得た結果である。
Figure 1 shows that 20 drops of blood containing heharin were first poured into a filter filled with various fibers in a column with a diameter of 1 cIfL at a density of 0.085 S'/-, and then 50 ml of physiological saline was poured. This is the result obtained.

白血球捕捉率とは、生理食塩水を流し終った時、フィル
ター内に残存している白血球数の、もとの血液中の白血
球数に対する割合をパーセント表示したものである。
The leukocyte capture rate is expressed as a percentage of the number of leukocytes remaining in the filter when the physiological saline has finished flowing, relative to the number of leukocytes in the original blood.

第2図は、ポリアクリル系繊維を直径1crfLのカラ
ムに、繊維表面積が2677ctAと一定となるように
つめたフィルターに、まずヘパリン加血液を20m1流
し、つぎに生理食塩水を5oml流して得た結果である
Figure 2 shows the results obtained by first flowing 20 ml of heparinized blood and then 5 oml of physiological saline through a filter filled with polyacrylic fibers packed in a column with a diameter of 1 crfL so that the fiber surface area was constant at 2677 ctA. This is the result.

リンパ球捕捉率とは、生理食塩水を流し終った時、フィ
ルター内に残存しているリンパ球数の、もとの血液中の
リンパ球数に対する割合を、パーセント表示したもので
ある。
The lymphocyte capture rate is the ratio of the number of lymphocytes remaining in the filter to the original number of lymphocytes in the blood when the physiological saline has finished flowing, expressed as a percentage.

なお、第1図、第2図とも、液体がフィルター内を流れ
る線速は一定としである。
Note that in both FIGS. 1 and 2, the linear velocity at which the liquid flows through the filter is assumed to be constant.

これらの図から明らかなように、平均直径が10ミクロ
ン以下の繊維を、ある程度の表面積をもたせてフィルタ
ーとすると、血液中の白血球をほとんど捕捉でき、また
同一表面積、同一平均繊維間距離の条件でも、平均直径
が10ミクロン以下の繊維をつめたフィルターの方が、
直径が10ミクロンより大きい繊維をつめたフィルター
よりリンハ球捕捉力が強い。
As is clear from these figures, if fibers with an average diameter of 10 microns or less are used as a filter and have a certain surface area, most of the leukocytes in the blood can be captured, and even under the conditions of the same surface area and the same average distance between fibers, , filters filled with fibers with an average diameter of 10 microns or less are better.
It has a stronger ability to capture Linha spheres than a filter filled with fibers larger than 10 microns in diameter.

、このフィルターにはこのような平均直径10ミクロン
以下の繊維がある程度入っていればよく、このものに他
の物質を混ぜてフィルターとしてもよい。
This filter only needs to contain a certain amount of such fibers with an average diameter of 10 microns or less, and may be mixed with other substances to form a filter.

たとえば、平均直径10ミクロン以下の繊維は、その種
類が異なるものや、平均直径が異なるもの、およびその
両者が異なるものの混合されたものでもよいことはもち
ろんである。
For example, it goes without saying that the fibers having an average diameter of 10 microns or less may be of different types, have different average diameters, or a mixture of both.

このように、本発明による白血球分離材を用いれば、血
液中の顆粒球・単球やリンパ球を容易な操作で短時間に
除去することができ、白血球を含まない赤血球浮遊液を
得ることができる。
As described above, by using the leukocyte separation material of the present invention, granulocytes, monocytes, and lymphocytes in blood can be removed in a short time with easy operations, and a red blood cell suspension containing no leukocytes can be obtained. can.

これを用いれば、通常の赤血球のみを必要とする患者に
全血輸血を行った際に生じる、組織適合抗原の違いに基
づ< GVH反応や、破壊された白血球成分による発熱
などの副作用を防止できるものと考えられる。
By using this, side effects such as GVH reactions based on differences in histocompatibility antigens and fever due to destroyed white blood cell components, which occur when whole blood transfusions are given to patients who require only normal red blood cells, can be prevented. It is considered possible.

一方、白血球分離材に捕捉された白血球を溶出し、白血
球浮遊液を得たり、またこのものから顆粒球・単球を除
き、リンパ球浮遊液を得ることも可能である。
On the other hand, it is also possible to elute the leukocytes captured in the leukocyte separation material to obtain a leukocyte suspension, or to remove granulocytes and monocytes from this to obtain a lymphocyte suspension.

分離材に捕捉された白血球を回収する手段としては、白
血球が分離材の繊維に粘着している場合は、粘着を阻害
する物質を加えるか、物理的外力を与えるか、または粘
着をおこしにくい条件に分離材をおくかすればよく、ま
た白血球が分離材の繊維がつくる空間にひっかかってい
る場合は、この空間を拡げたり、繊維を振動させながら
液を流すことにより、白血球の回収が可能となる。
If the leukocytes are stuck to the fibers of the separation material, methods for recovering the leukocytes captured in the separation material include adding a substance that inhibits adhesion, applying physical external force, or using conditions that make it difficult to cause adhesion. If the white blood cells are stuck in the space created by the fibers of the separation material, it is possible to collect the white blood cells by expanding this space or by flowing the liquid while vibrating the fibers. .

また、血球浮遊液をこの分離材と接触させる前に、デキ
ストランなどの赤血球凝集剤をあらかじめ加え、赤血球
の少ない血球浮遊液を得、これを本発明による白血球分
離材と接触させ、分離材をよく洗浄しておくと、回収さ
れた白血球浮遊液中の赤血球を、一層少なくすることが
できる。
Furthermore, before bringing the blood cell suspension into contact with this separation material, a red blood cell agglutinating agent such as dextran is added in advance to obtain a blood cell suspension containing few red blood cells. By washing, the number of red blood cells in the collected white blood cell suspension can be further reduced.

このようにして得た白血球中の顆粒球・単球は、貧食能
、走化性などがよく保たれており、またリンパ球は種々
の分裂原、たとえばフィトヘマグルチニンやポー7・ウ
イード・マイトジェンによって他の方法によって得たリ
ンパ球と同程度に幼若化することができる。
The granulocytes and monocytes among the white blood cells obtained in this way have well-preserved poor phagocytic ability and chemotaxis, and the lymphocytes contain various mitogens such as phytohemagglutinin, Po-7, weed, and mitogen. By this method, lymphocytes obtained by other methods can be transformed to the same extent as lymphocytes.

またT細胞・B細胞の比率も、もとの血球浮遊液とあま
り変わっていない。
Also, the ratio of T cells and B cells is not much different from the original blood cell suspension.

以上に述べたように、本発明による白血球分離材は、血
液中の白血球を効率よく除去できるとともに、分離材に
捕捉された白血球を回収することにより、純度・収率よ
く簡単な操作で白血球浮遊液を得ることができ、各種医
療施設においてこれらの成分輸血が容易に実施できるも
のである。
As described above, the leukocyte separation material according to the present invention can efficiently remove leukocytes from blood, and by recovering leukocytes captured by the separation material, leukocyte suspension can be achieved with high purity and yield with simple operation. These components can be easily transfused at various medical facilities.

実施例 1 直径が5.2ミクロン、長さが4crfLから7crr
Lのアクリロニトリル系合成繊維を、直径2cm、長さ
10crILのカラムに2.7z均一につめた白血球分
離フィルターをつくった。
Example 1 Diameter: 5.2 microns, length: 4crfL to 7crr
A leukocyte separation filter was made by uniformly packing 2.7z L of acrylonitrile synthetic fibers into a column with a diameter of 2 cm and a length of 10 crIL.

このフィルターに健康人の血液を5rrLl/rfuI
Lの流速で100TI′Ll流し、つぎに生理食塩水を
5 ml/yniyiの流速で30m1流して、フィル
ター内の赤血球を回収した。
Put 5rrLl/rfuI of healthy human blood into this filter.
The red blood cells in the filter were collected by flowing 100 TI'Ll at a flow rate of 10 L, and then flowing 30 ml of physiological saline at a flow rate of 5 ml/yniyi.

この液には、白血球はもとの3%、赤血球はもとの93
%含まれていた。
This fluid contains 3% of the original white blood cells and 93% of the original red blood cells.
% was included.

実施例 2 直径が9.6ミクロン、長さが4crfLから7cmの
ポリエステル系合成繊維を、直径が2CIrL、長さ1
0αのカラムに41均一につめた白血球分離フィルター
をつくった。
Example 2 A polyester synthetic fiber with a diameter of 9.6 microns and a length of 4 crfL to 7 cm was fabricated with a diameter of 2 CIrL and a length of 1 cm.
A leukocyte separation filter was prepared in which 41 cells were uniformly packed in a 0α column.

このフィルターに健康人の血液を5′/nl/−の流速
で100m1流し、つぎに生理食塩水をl 0rul/
m1ytの流速で200m1流して、フィルター内に残
存している赤血球を大部分流し出した。
100ml of healthy blood was passed through this filter at a flow rate of 5'/nl/-, and then physiological saline was poured into the filter at a flow rate of 100ml/nl/-.
Most of the red blood cells remaining in the filter were washed out by flowing 200 ml at a flow rate of mlyt.

この後、血漿を含む生理的溶液を5ml/m1ttの流
速で100TILl流してフィルターに物理的外力を与
えながら、フィルター内の白血球を回収した。
Thereafter, 100 TILl of physiological solution containing plasma was flowed at a flow rate of 5 ml/mltt to apply physical external force to the filter, and leukocytes in the filter were collected.

この液には、白血球はもとの55%、赤血球はもとの0
.2%、血小板はもとの8%含まれていた。
This fluid contains 55% of the original white blood cells and 0 of the original red blood cells.
.. 2%, and platelets were 8% of the original.

実施例 3 直径が9.8ミクロン、長さが4cffLから7cmの
アクリロニトリル系合成繊維を直径2CrrL、長さ1
0ののカラムに4z均一につめた白血球分離フィルター
をつくった。
Example 3 Acrylonitrile synthetic fibers with a diameter of 9.8 microns and a length of 4 cffL to 7 cm were made into 2 CrrL in diameter and 1 cm in length.
A leukocyte separation filter was made in which 4z cells were uniformly packed in a 0 column.

これに健康人の血液100m1′に分子量20万のデキ
ストラン溶液を加えて得た、赤血球かもとの3%、白血
球かもとの65%となった液を通し、つぎに生理的食塩
水を200mA’流して、フィルター内の残存赤血球を
大部分流し出した。
A solution obtained by adding a dextran solution with a molecular weight of 200,000 to 100 ml of blood from a healthy person, with a concentration of 3% red blood cells and 65% white blood cells, was passed through this, and then physiological saline was added at 200 mA'. Most of the remaining red blood cells in the filter were washed out by flushing.

この後、血漿を含む生理的溶液を100m1流して、フ
ィルターに物理的外力を与えながら、フィルター内の白
血球を回収した。
Thereafter, 100 ml of a physiological solution containing plasma was flowed to collect the white blood cells inside the filter while applying physical external force to the filter.

この液には、白血球はもとの血液の40%、赤血球は0
.02%、血小板は0.6%含まれていた。
This fluid contains 40% white blood cells and 0 red blood cells.
.. It contained 0.02% and platelets 0.6%.

実施例 4 種々の平均直径を持つ、長さ4crILから7αのアク
リロニトリル系合成繊維を0.085 ?/c11tの
充填密度で、直径1crrL1長さ10crILのカラ
ムに詰め、これに健康人の血液20−を2 trtl/
m1yrで流し、次に生食30WLlを5 rrtl/
vtinで流した時の、フィルター内白血球捕捉率を第
3図に示す。
Example 4 Acrylonitrile synthetic fibers with lengths from 4crIL to 7α having various average diameters were made from 0.085? A column with a diameter of 1 crrL and a length of 10 crIL is packed at a packing density of /c11t, and 20 - of healthy human blood is poured into this column at a packing density of 2 trtl/c11t.
Rinse with mlyr, then add 30WLl of raw food to 5rrtl/
Figure 3 shows the leukocyte capture rate in the filter when flowing with vtin.

第3図における曲線aはリンパ球の捕捉率:bは顆粒球
の捕捉率である。
Curve a in FIG. 3 is the capture rate of lymphocytes, and curve b is the capture rate of granulocytes.

この図から明らかなように、平均直径がIOμ以下では
、10μより大きい繊維径を詰めたものに比べて、リン
パ球、顆粒球の捕捉率が良い。
As is clear from this figure, when the average diameter is IOμ or less, the capturing rate of lymphocytes and granulocytes is better than when the fiber diameter is larger than 10μ.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は、種々の繊維の白血球捕捉率を示すグラフであ
る。 第2図は、平均繊維間距離と、リンパ球捕捉率との関係
を示すグラフである。 第3図は、繊維径と白血球捕捉率の関係を示すグラフで
ある。
FIG. 1 is a graph showing the leukocyte capture rate of various fibers. FIG. 2 is a graph showing the relationship between the average interfiber distance and the lymphocyte capture rate. FIG. 3 is a graph showing the relationship between fiber diameter and leukocyte capture rate.

Claims (1)

【特許請求の範囲】 1 平均直径が10ミクロン以下の、血液を変性させな
い合成繊維、半合成繊維、再生人造繊維無機繊維または
天然繊維からなる白血球分離材。 2 繊維が、ポリアミド、ポリエステル、ポ’J 7ク
リロニトリル系、アセテートから選ばれたものであるこ
とを特徴とする特許請求の範囲第1項記載の白血球分離
材。
[Scope of Claims] 1. A leukocyte separation material made of synthetic fibers, semi-synthetic fibers, regenerated artificial fibers, inorganic fibers, or natural fibers that do not denature blood and have an average diameter of 10 microns or less. 2. The leukocyte separation material according to claim 1, wherein the fibers are selected from polyamide, polyester, po'J7crylonitrile, and acetate.
JP53024455A 1978-03-06 1978-03-06 Leukocyte separation material Expired JPS5854126B2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP53024455A JPS5854126B2 (en) 1978-03-06 1978-03-06 Leukocyte separation material
GB7907537A GB2018151B (en) 1978-03-06 1979-03-02 Seperation of leukocytes from leukocyte-containing suspension by filtration
FR7905629A FR2419073A1 (en) 1978-03-06 1979-03-05 SEPARATION OF LEUCOCYTES FROM A SUSPENSION IN A CONTAINER, BY FILTRATION
DE2908722A DE2908722C2 (en) 1978-03-06 1979-03-06 Filter unit for separating leukocytes
US06/170,384 US4330410A (en) 1978-03-06 1980-07-21 Separation of leukocytes from leukocyte-containing suspension by filtration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP53024455A JPS5854126B2 (en) 1978-03-06 1978-03-06 Leukocyte separation material

Publications (2)

Publication Number Publication Date
JPS54119013A JPS54119013A (en) 1979-09-14
JPS5854126B2 true JPS5854126B2 (en) 1983-12-02

Family

ID=12138628

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53024455A Expired JPS5854126B2 (en) 1978-03-06 1978-03-06 Leukocyte separation material

Country Status (1)

Country Link
JP (1) JPS5854126B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006025371A1 (en) 2004-08-30 2006-03-09 Kaneka Corporation Granulocyte adsorbent

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62266069A (en) * 1986-05-12 1987-11-18 テルモ株式会社 Filter for fractionating and purifying erythrocyte
IL88081A0 (en) * 1987-10-20 1989-06-30 Pall Corp Device and method for depletion of the leucocyte content of blood and blood components

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5335587B2 (en) * 1972-03-08 1978-09-28

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5921813Y2 (en) * 1976-09-02 1984-06-28 テルモ株式会社 Blood granulocyte collection filter

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5335587B2 (en) * 1972-03-08 1978-09-28

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006025371A1 (en) 2004-08-30 2006-03-09 Kaneka Corporation Granulocyte adsorbent

Also Published As

Publication number Publication date
JPS54119013A (en) 1979-09-14

Similar Documents

Publication Publication Date Title
US4330410A (en) Separation of leukocytes from leukocyte-containing suspension by filtration
JPS603367B2 (en) Leukocyte separation method and leukocyte separation material
DE69332926T2 (en) CONTINUOUS CENTRIFUGATION METHOD FOR SEPARATING BIOLOGICAL COMPONENTS FROM HETEROGENIC CELL POPULATIONS
JPH0663131A (en) Method for selectively removing leucocyte
JPH03173825A (en) Filter for purifying blood platelet
US4663058A (en) Process for continuous separation of leukocyte/platelet-enriched fraction from whole blood
CA2261612A1 (en) Method for removing tumor cells from tumor cell-contaminated stem cell products
KR910006820B1 (en) Leucocyte seperating filter
JPS5854126B2 (en) Leukocyte separation material
JPS5854125B2 (en) Leukocyte separation filter and leukocyte separation method
JPS5854130B2 (en) Leukocyte separation method
JPH08104643A (en) Method for removing erythrocyte
JP2004129550A (en) Method for separating and recovering monocyte
JPS6324975B2 (en)
JPS5854129B2 (en) Lymphocyte separation method
JPS5854131B2 (en) How to isolate leukocytes
JPS6330887B2 (en)
JPS6326089B2 (en)
JP4437335B2 (en) Human undifferentiated hematopoietic stem cells, separation method and separation apparatus thereof
JPS5854128B2 (en) Lymphocyte isolation method and device
JPS5936886B2 (en) How to isolate white blood cells
JP3938973B2 (en) Cell separation method
JPH11335289A (en) Removal of blood platelet and cell composition
JPS5914008B2 (en) Lymphocyte collection method and device
JPH09121849A (en) Cell collection system and cell collection